About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 104892, 8 pages
http://dx.doi.org/10.1155/2013/104892
Clinical Study

Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study

1Division of Nephrology, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 17, 1011 Lausanne, Switzerland
2AARDEX Group Ltd., Rue des Cyclistes Frontiére 24, B4600 Visé, Belgium

Received 2 April 2013; Revised 5 June 2013; Accepted 9 June 2013

Academic Editor: Christian-Heinz Anderwald

Copyright © 2013 Valentina Forni Ogna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Valentina Forni Ogna, Menno Pruijm, Carole Zweiacker, Grégoire Wuerzner, Eric Tousset, and Michel Burnier, “Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study,” BioMed Research International, vol. 2013, Article ID 104892, 8 pages, 2013. doi:10.1155/2013/104892